{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:13:03Z","timestamp":1791191583980,"version":"4.1.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2009,9,1]],"date-time":"2009-09-01T00:00:00Z","timestamp":1251763200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T00:00:00Z","timestamp":1673395200000},"content-version":"vor","delay-in-days":4880,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["mp.uscap.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Modern Pathology"],"published-print":{"date-parts":[[2009,9]]},"DOI":"10.1038\/modpathol.2009.92","type":"journal-article","created":{"date-parts":[[2009,6,12]],"date-time":"2009-06-12T10:23:42Z","timestamp":1244802222000},"page":"1243-1250","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas"],"prefix":"10.1016","volume":"22","author":[{"given":"Celestine S","family":"Tung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel C","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne T M","family":"Tsang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhifei","family":"Zu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huijuan","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinsong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Deavers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anais","family":"Malpica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith K","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen H","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Gershenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwong-Kwok","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1038\/modpathol.2009.92_bib1","unstructured":"American Cancer Society. Overview: Ovarian Cancer; How many women get ovarian cancer?. 2008 [cited 9-11-2008]; Available from:www.cancer.org."},{"key":"10.1038\/modpathol.2009.92_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1097\/01.pgp.0000101080.35393.16","article-title":"The histologic type and stage distribution of ovarian carcinomas of surface epithelial origin","volume":"23","author":"Seidman","year":"2004","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2009.92_bib3","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1046\/j.1525-1438.1993.03020072.x","article-title":"Reproducibility and prognostic value of histologic type and grade in early epithelial ovarian cancer","volume":"3","author":"Bertelsen","year":"1993","journal-title":"Int J Gynecol Cancer"},{"key":"10.1038\/modpathol.2009.92_bib4","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/00000478-200404000-00009","article-title":"Grading ovarian serous carcinoma using a two-tier system","volume":"28","author":"Malpica","year":"2004","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.92_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1097\/PAS.0b013e31802cbbe9","article-title":"The development of high-grade serous carcinoma from atypical proliferative (borderline) serous tumors and low-grade micropapillary serous carcinoma: a morphologic and molecular genetic analysis","volume":"31","author":"Dehari","year":"2007","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.92_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1097\/01.AOG.0000227787.24587.d1","article-title":"Clinical behavior of stage II\u2013IV low-grade serous carcinoma of the ovary","volume":"108","author":"Gershenson","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1038\/modpathol.2009.92_bib7","first-page":"255","article-title":"Ovarian surface epithelium: biology, endocrinology, and pathology","volume":"22","author":"Auersperg","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1038\/modpathol.2009.92_bib8","doi-asserted-by":"crossref","first-page":"5284","DOI":"10.1200\/JCO.2008.18.1107","article-title":"New insights into the pathogenesis of serous ovarian cancer and its clinical impact","volume":"26","author":"Levanon","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.92_bib9","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/S0140-6736(71)92335-X","article-title":"Incessant ovulation\u2014a factor in ovarian neoplasia?","volume":"2","author":"Fathalla","year":"1971","journal-title":"Lancet"},{"key":"10.1038\/modpathol.2009.92_bib10","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1038\/modpathol.3800827","article-title":"Expression of PAX2 in papillary serous carcinoma of the ovary: immunohistochemical evidence of fallopian tube or secondary Mullerian system origin?","volume":"20","author":"Tong","year":"2007","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.92_bib11","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/path.1000","article-title":"Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer","volume":"195","author":"Piek","year":"2001","journal-title":"J Pathol"},{"key":"10.1038\/modpathol.2009.92_bib12","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1200\/JCO.2006.07.9970","article-title":"Early events in the pathogenesis of epithelial ovarian cancer","volume":"26","author":"Landen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1038\/modpathol.2009.92_bib13","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1073\/pnas.98.1.31","article-title":"Model-based analysis of oligonucleotide arrays: expression index computation and outlier detection","volume":"98","author":"Li","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1038\/modpathol.2009.92_bib14","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1593\/neo.08604","article-title":"Clusterin interacts with Paclitaxel and confer Paclitaxel resistance in ovarian cancer","volume":"10","author":"Park","year":"2008","journal-title":"Neoplasia"},{"key":"10.1038\/modpathol.2009.92_bib15","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1038\/sj.onc.1205172","article-title":"Expression of the PAX2 oncogene in human breast cancer and its role in progesterone-dependent mammary growth","volume":"21","author":"Silberstein","year":"2002","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2009.92_bib16","first-page":"4092","article-title":"Expression of Pax-2 in human renal cell carcinoma and growth inhibition by antisense oligonucleotides","volume":"55","author":"Gnarra","year":"1995","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.92_bib17","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/01.pas.0000146025.91953.8d","article-title":"Patterns of p53 mutations separate ovarian serous borderline tumors and low- and high-grade carcinomas and provide support for a new model of ovarian carcinogenesis: a mutational analysis with immunohistochemical correlation","volume":"29","author":"Singer","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.92_bib18","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/01.pas.0000166367.68459.7d","article-title":"An immunohistochemical comparison between low-grade and high-grade ovarian serous carcinomas: significantly higher expression of p53, MIB1, BCL2, HER-2\/neu, and C-KIT in high-grade neoplasms","volume":"29","author":"O'Neill","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.92_bib19","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1365-2559.2007.02682.x","article-title":"High-grade ovarian serous carcinoma exhibits significantly higher p16 expression than low-grade serous carcinoma and serous borderline tumour","volume":"50","author":"O'Neill","year":"2007","journal-title":"Histopathology"},{"key":"10.1038\/modpathol.2009.92_bib20","doi-asserted-by":"crossref","first-page":"10602","DOI":"10.1158\/0008-5472.CAN-05-2240","article-title":"Expression profiling of serous low malignant potential, low-grade, and high-grade tumors of the ovary","volume":"65","author":"Bonome","year":"2005","journal-title":"Cancer Res"},{"key":"10.1038\/modpathol.2009.92_bib21","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1097\/pgp.0b013e31803025cd","article-title":"Significantly greater expression of ER, PR, and ECAD in advanced-stage low-grade ovarian serous carcinoma as revealed by immunohistochemical analysis","volume":"26","author":"Wong","year":"2007","journal-title":"Int J Gynecol Pathol"},{"key":"10.1038\/modpathol.2009.92_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1097\/01.pas.0000164030.82810.db","article-title":"Ovarian serous tumors of low malignant potential (borderline tumors): outcome-based study of 276 patients with long-term (> or =5-year) follow-up","volume":"29","author":"Longacre","year":"2005","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.92_bib23","first-page":"3","article-title":"Response and survival in patients with progressive or recurrent serous ovarian tumors of low malignant potential","volume":"99","author":"Crispens","year":"2002","journal-title":"Obstet Gynecol"},{"key":"10.1038\/modpathol.2009.92_bib24","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/01.pas.0000213294.81154.95","article-title":"The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent","volume":"30","author":"Silva","year":"2006","journal-title":"Am J Surg Pathol"},{"key":"10.1038\/modpathol.2009.92_bib25","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S0168-9525(01)02594-X","article-title":"Getting your Pax straight: Pax proteins in development and disease","volume":"18","author":"Chi","year":"2002","journal-title":"Trends Genet"},{"key":"10.1038\/modpathol.2009.92_bib26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1038\/nrc1778","article-title":"A PANorama of PAX genes in cancer and development","volume":"6","author":"Robson","year":"2006","journal-title":"Nat Rev Cancer"},{"key":"10.1038\/modpathol.2009.92_bib27","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1038\/modpathol.3800535","article-title":"PAX2: a reliable marker for nephrogenic adenoma","volume":"19","author":"Tong","year":"2006","journal-title":"Mod Pathol"},{"key":"10.1038\/modpathol.2009.92_bib28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1034\/j.1399-0004.1999.560101.x","article-title":"Renal-coloboma syndrome: a multi-system developmental disorder caused by PAX2 mutations","volume":"56","author":"Eccles","year":"1999","journal-title":"Clin Genet"},{"key":"10.1038\/modpathol.2009.92_bib29","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1016\/S0022-5347(05)66304-5","article-title":"Expression of the developmental and oncogenic PAX2 gene in human prostate cancer","volume":"165","author":"Khoubehi","year":"2001","journal-title":"J Urol"},{"key":"10.1038\/modpathol.2009.92_bib30","first-page":"447","article-title":"The paired-box transcription factor, PAX2, positively modulates expression of the Wilms' tumor suppressor gene (WT1)","volume":"13","author":"Dehbi","year":"1996","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2009.92_bib31","doi-asserted-by":"crossref","first-page":"4136","DOI":"10.1074\/jbc.M306824200","article-title":"Role of Pax2 in apoptosis resistance and proinvasive phenotype of Kaposi's sarcoma cells","volume":"279","author":"Buttiglieri","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1038\/modpathol.2009.92_bib32","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/S0002-9440(10)64597-X","article-title":"PAX2 suppresses apoptosis in renal collecting duct cells","volume":"157","author":"Torban","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1038\/modpathol.2009.92_bib33","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1046\/j.1442-2042.2001.00244.x","article-title":"Aberrant expression of Pax-2 mRNA in renal cell carcinoma tissue and parenchyma of the affected kidney","volume":"8","author":"Igarashi","year":"2001","journal-title":"Int J Urol"},{"key":"10.1038\/modpathol.2009.92_bib34","doi-asserted-by":"crossref","first-page":"7989","DOI":"10.1038\/sj.onc.1206766","article-title":"Paired-Box genes are frequently expressed in cancer and often required for cancer cell survival","volume":"22","author":"Muratovska","year":"2003","journal-title":"Oncogene"},{"key":"10.1038\/modpathol.2009.92_bib35","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1038\/sj.ki.5000136","article-title":"PAX2 inactivation enhances cisplatin-induced apoptosis in renal carcinoma cells","volume":"69","author":"Hueber","year":"2006","journal-title":"Kidney Int"}],"container-title":["Modern Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/modpathol200992.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol200992","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0893395222024772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/modpathol200992.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T01:01:05Z","timestamp":1760230865000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0893395222024772"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,9]]},"references-count":35,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2009,9]]}},"alternative-id":["S0893395222024772"],"URL":"https:\/\/doi.org\/10.1038\/modpathol.2009.92","relation":{},"ISSN":["0893-3952"],"issn-type":[{"value":"0893-3952","type":"print"}],"subject":[],"published":{"date-parts":[[2009,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PAX2 expression in low malignant potential ovarian tumors and low-grade ovarian serous carcinomas","name":"articletitle","label":"Article Title"},{"value":"Modern Pathology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1038\/modpathol.2009.92","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2009 United States & Canadian Academy of Pathology.","name":"copyright","label":"Copyright"}]}}